Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response

Clinical and Experimental Immunology

Volumn 170, Issue 3, 2012, Pages 310-320

  Fraccaroli, L ^a   Grasso, E ^a   Hauk, V ^a   Cortelezzi, M ^b   Calo, G ^a   Perez Leiros C ^a   Ramhorst, R ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Argentinean Society of Gynecological and Endocrinological Reproduction   (Argentina)

Author keywords

Maternal tolerance; Recurrent spontaneous abortions; VIP

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; IN VITRO STUDY; LEUKOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUS ABORTION; TROPHOBLAST;

ADULT; CELL COMMUNICATION; EMBRYO IMPLANTATION; EMBRYO LOSS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; PLACENTA; PREGNANCY; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY; TROPHOBLASTS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84868247362     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04668.x     Document Type: Article

References (48)

1. Abrahams V, Visitin I, Aldo P, Guller S, Romero R, Mor G. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 2005; 176:8096-8104.
2. Rugeles MT, Shearer GM. Alloantigen recognition in utero: dual advantage for the fetus? Trends Immunol 2004; 25:348-352.
3. Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA. Tolerance signalling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 2007; 58:238-254.
4. Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS. Inflammation in reproductive disorders. Reprod Sci 2009; 16:216-229.
5. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009; 15:517-535.
6. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007; 29:95-113.
7. Chaouat G, Petibarat M, Dubanchet S, Rahmati M, Leedée N. Tolerance to fetal allograft? Am J Reprod Immunol 2010; 62:624-636.
8. Paria B, Reese J, Das S, Dey S. Deciphering the cross talk of implantation: advances and challenges. Science 2002; 296:2185-2188.
9. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 62:601-610.
10. Aluvihare V, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
11. Blois SM, Ilarregui JM, Tometten M etal. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:1450-1457.
12. Molvarec A, Blois SM, Stenczer B etal. Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia. Clin Immunol 2011; 139:48-56.
13. Yosinaga K Research on blastoyst implantation essential factors (BIEFs). Am J Reprod Immunol 2010; 62:624-636.
14. Fraccaroli L, Alfieri J, Larocca L etal. VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells. Br J Pharmacol 2009; 156:116-126.
15. Leceta J, Gomariz RP, Martinez C, Carrión M, Arranz A, Juarranz Y. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation. Neuroimmunomodulation 2007; 14:134-138.
16. Gonzalez-Rey E, Anderson P, Delgado M. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy. Ann Rheum Dis 2007; 66:70-76.
17. Rosignoli F, Torroba M, Juarranz J etal. VIP and tolerance induction in autoimmunity. Ann NY Acad Sci 2006; 1070:525-530.
18. Ekström J, Mansson B, Tobin G. Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity. Acta Physiol Scand 1983; 119:169-175.
19. Spong C, Lee S, Mcune S etal. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 1999; 140:917-924.
20. Roca V, Calafat M, Larocca L etal. Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice. Reproduction 2009; 138:733-742.
21. Coulam CB, Clark DA, Kutteh WH, Kwak S, Stephenson M. Current clinical options for diagnosis and treatment of recurrent spontaneous abortions. Am J Reprod Immunol 1997; 38:57-74.
22. Straszewski-Chavez SL, Abrahams VM, Alvero AB etal. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta 2009; 30:939-948.
23. Aplin JD, Straszewski-Chavez SL, Kalions B etal. Trophoblast differentiation: progenitor cells, fusion and migration. A workshop report. Placenta 2006; 27 (Suppl A):S141-143.
24. Gozes I, Brenneman DE. VIP: molecular biology and neurobiological function. Mol Neurobiol 1989; 3:201-236.
25. Wheeler S, Eardley JE, McNulty KF, Sutcliffe CP, Morrison JD. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats. Exp Physiol 1997; 82:729-747.
26. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141:2404-2412.
27. Pregi N, Vittori D, Pérez G, Pérez Leirós C, Nesse A. Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells. Biochim Biophys Acta 2006; 1763:238-246.
28. Huang SJ, Schatz F, Masch R etal. Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J Reprod Immunol 2006; 72:60-73.
29. Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol 2007; 8:5-6.
30. Kwak-Kim J, Yang KM, Gilman-Sachs A. Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynaecol Res 2009; 35:609-622.
31. Leber A, Teles A, Zenclussen AC. Regulatory T cells and their role in pregnancy. Am J Reprod Immunol 2010; 63:445-459.
32. Pozo D, Anderson P, Gonzalez-Rey E. Regulatory cells by vasoactive intestinal peptide. J Immunol 2009; 183:4346-4359.
33. Gonzalez-Rey E, Ganea D, Delgado M. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance. Curr Opin Pharmacol 2010; 10:473-481.
34. Mor G. Inflammation and pregnancy the role of Toll-like receptors in trophoblast-immune interaction. Ann NY Acad Sci 2008; 1127:121-128.
35. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63:425-433.
36. Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 2011; 141:715-724.
37. Abad C, Gomariz RP, Waschek JA. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr Top Med Chem 2006; 6:151-163.
38. Armstrong BD, Hu Z, Abad C etal. Lymphocyte regulation of neuropeptide gene expression after neuronal injury. J Neurosc Res 2003; 15:240-247.
39. Delgado M, Abad C, Martinez C, Juarranz MG. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med 2002; 80:16-24.
40. Gomariz RP, Martinez C, Abad C, Leceta J, Delgado M. Immunology of VIP: a review and therapeutical perspectives. Curr Pharm Des 2001; 7:89-111.
41. Onoue S, Misaka S, Aoki Y etal. Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15, 20, 21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats. Eur J Pharm Sci 2010; 41:508-514.
42. Girard BA, Lelievre V, Braas KM etal. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. J Neurochem 2006; 99:499-513.
43. Hill JM, Cuasay K, Abebe DT. Vasoactive intestinal peptide antagonist treatment during mouse embryogenesis impairs social behavior and cognitive function of adult male offspring. Exp Neurol 2007; 206:101-113.
44. Ledee-Bataille N, Dubanchet S, Coulomb-L'hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004; 81:59-65.
45. Ramhorst R, Fraccaroli L, Aldo P etal. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol 2012; 67:17-27.
46. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007; 178:2572-2578.
47. Baek KH, Lee EJ, Kim YS. Recurrent pregnancy loss: the key potential mechanisms. Trends Mol Med 2007; 13:310-317.
48. Toth B, Jeschkec U, Rogenhoferb N etal. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol 2010; 85:25-32.